State Street’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,699
| Closed | -$7K | – | 3988 |
|
|
2020
Q4 | $7K | Sell |
13,699
-21,800
| -61% | -$11K | ﹤0.01% | 3884 |
|
|
2020
Q3 | $19K | Hold |
35,499
| – | – | ﹤0.01% | 3799 |
|
|
2020
Q2 | $24K | Sell |
35,499
-1,258,779
| -97% | -$1.01M | ﹤0.01% | 3764 |
|
|
2020
Q1 | $1.09M | Buy |
1,294,278
+87,742
| +7% | +$125K | ﹤0.01% | 3284 |
|
|
2019
Q4 | $1.98M | Buy |
1,206,536
+69,169
| +6% | +$104K | ﹤0.01% | 3256 |
|
|
2019
Q3 | $1.26M | Buy |
1,137,367
+88,692
| +8% | +$103K | ﹤0.01% | 3352 |
|
|
2019
Q2 | $1.3M | Buy |
1,048,675
+91,294
| +10% | +$116K | ﹤0.01% | 3371 |
|
|
2019
Q1 | $1.38M | Sell |
957,381
-256,220
| -21% | -$380K | ﹤0.01% | 3272 |
|
|
2018
Q4 | $1.43M | Sell |
1,213,601
-56,407
| -4% | -$83.7K | ﹤0.01% | 3238 |
|
|
2018
Q3 | $1.72M | Buy |
1,270,008
+234,019
| +23% | +$371K | ﹤0.01% | 3301 |
|
|
2018
Q2 | $2.37M | Buy |
1,035,989
+128,633
| +14% | +$248K | ﹤0.01% | 3184 |
|
|
2018
Q1 | $1.37M | Buy |
907,356
+150,733
| +20% | +$177K | ﹤0.01% | 3288 |
|
|
2017
Q4 | $572K | Sell |
756,623
-17,805
| -2% | -$15.9K | ﹤0.01% | 3429 |
|
|
2017
Q3 | $898K | Sell |
774,428
-4,300
| -0.6% | -$5.42K | ﹤0.01% | 3402 |
|
|
2017
Q2 | $1.35M | Buy |
778,728
+26,825
| +4% | +$57K | ﹤0.01% | 3270 |
|
|
2017
Q1 | $1.99M | Buy |
751,903
+17,314
| +2% | +$62.2K | ﹤0.01% | 3089 |
|
|
2016
Q4 | $3.12M | Buy |
734,589
+99,474
| +16% | +$328K | ﹤0.01% | 2914 |
|
|
2016
Q3 | $1.7M | Buy |
635,115
+12,259
| +2% | +$28.2K | ﹤0.01% | 3036 |
|
|
2016
Q2 | $1.1M | Buy |
622,856
+217,974
| +54% | +$445K | ﹤0.01% | 3250 |
|
|
2016
Q1 | $936K | Buy |
404,882
+9,369
| +2% | +$21.2K | ﹤0.01% | 3232 |
|
|
2015
Q4 | $1.37M | Buy |
395,513
+9,239
| +2% | +$44.2K | ﹤0.01% | 3126 |
|
|
2015
Q3 | $2.36M | Buy |
386,274
+3,388
| +0.9% | +$23K | ﹤0.01% | 2930 |
|
|
2015
Q2 | $2.53M | Buy |
382,886
+8,021
| +2% | +$54.1K | ﹤0.01% | 2972 |
|
|
2015
Q1 | $2.67M | Buy |
+374,865
| New | +$2.83M | ﹤0.01% | 2907 |
|
Other funds holding GEN
IC
TRCT
State Street's GEN Position: Q1 2021 in Review
State Street sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 13,699 shares — an estimated $7K sold.
State Street first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $3.12M in Q4 2016. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- State Street reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- State Street sold 13,699 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $7K.
- State Street first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
- State Street's Genesis Healthcare, Inc. position peaked at $3.12M in Q4 2016.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on State Street's 13F filing for Q1 2021, filed 17 May 2021.